Overall, SMS2 deficiency can reduce the infiltration of TAMs in the pancreatic cancer microenvironment, as well as the infiltration of other immunosuppressive cells, such as Tregs and CAFs, thereby significantly slowing tumor progression. The gene discussed is SGMS2; the disease is familial pancreatic carcinoma.